Document is current
Any future updates will be listed below
-
Authors
Beck, Belinda http://orcid.org/0000-0003-1295-6395
Rubin, Clinton
Harding, Amy
Paul, Sanjoy
Forwood, Mark
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (APP1084376)
- License Information
-
More Information
Article History
Received: 25 May 2021
Accepted: 3 December 2021
First Online: 6 January 2022
Declarations
:
: This study has been approved by the Griffith University Human Research Ethics Committee: Protocol number AHS/61/14/HREC. Written, informed consent to participate will be obtained from all participants.
: Not applicable.
: BRB is Director of The Bone Clinic, Brisbane, QLD, Australia. CTR is founder of Marodyne Medical, and an inventor of the LivMD LIV device. SKP has acted as a consultant and/or speaker for Novartis, GI Dynamics, Roche, AstraZeneca, Guangzhou Zhongyi Pharmaceutical and Amylin Pharmaceuticals LLC. He has received grants in support of investigator and investigator initiated clinical studies from Merck, Novo Nordisk, AstraZeneca, Hospira, Amylin Pharmaceuticals, Sanofi-Aventis, and Pfizer. All other authors declare that they have no competing interests.
